Contraindications and Precautions Do NOT use AOD-9604 if you: Are pregnant, trying to conceive, or breastfeeding (no safety data in pregnancy/lactation) Have active cancer or history of malignancy (peptide effects on existing cancer unknown) Are under 18 years of age (pediatric safety not established) Have known hypersensitivity to peptides or benzyl alcohol (in bacteriostatic water) Have severe kidney or liver disease without physician clearance Use with caution and enhanced monitoring if you have: Diabetes or glucose metabolism disorders (monitor blood sugar closely despite no expected impact) Cardiovascular disease (comprehensive cardiac evaluation recommended) Thyroid disorders (monitor thyroid function during therapy) History of migraines (may increase headache frequency in susceptible individuals) Drug Interactions Limited formal drug interaction studies exist for AOD-9604
Strength improvements become measurable by 4-6 weeks
But a common question patients have is: Does enclomiphene
Schedule: Daily subcutaneous injections for 48 weeks
APC 5593 contains procedures that describe nuclear medicine tests, not MRI services
However, the currently dominant ontologies, epistemologies, methodologies and tools of these disciplines are inadequate to open up alternative epistemic possibilities and imagine alternative pathways compatible with contemporary imperatives for equity, justice, health and wellbeing
